• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bone mineral density and disorders of mineral metabolism in chronic liver disease.慢性肝病中的骨矿物质密度与矿物质代谢紊乱
World J Gastroenterol. 2009 Jul 28;15(28):3516-22. doi: 10.3748/wjg.15.3516.
2
Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.布鲁克林一个极端正统犹太社区青少年的脊柱骨密度降低。
Pediatrics. 2001 May;107(5):E79. doi: 10.1542/peds.107.5.e79.
3
Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.接受原位肝移植的肝硬化患者的骨质疏松症和骨矿物质代谢紊乱
Calcif Tissue Int. 1997 Feb;60(2):148-54. doi: 10.1007/s002239900205.
4
Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.囊性纤维化患者骨矿物质密度和骨转换分析:胰岛素样生长因子系统与炎性细胞因子之间的关联
Horm Res. 2006;66(4):162-8. doi: 10.1159/000094143. Epub 2006 Jun 23.
5
Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.胰岛素依赖型糖尿病中的骨质减少;患病率及病理生理学方面
J Endocrinol Invest. 2000 May;23(5):295-303. doi: 10.1007/BF03343726.
6
Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density.慢性肝病患者胰岛素样生长因子及其结合蛋白的循环水平:与骨矿物质密度缺乏相关性。
Liver. 2001 Apr;21(2):123-8. doi: 10.1034/j.1600-0676.2001.021002123.x.
7
The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.胰岛素样生长因子 1、胰岛素样生长因子结合蛋白 3 及骨密度在埃及开罗慢性丙型肝炎病毒患者中的潜在作用。
Trans R Soc Trop Med Hyg. 2010 Jun;104(6):429-32. doi: 10.1016/j.trstmh.2010.01.012. Epub 2010 Mar 1.
8
Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics.慢性酒精中毒患者脊柱和股骨骨量减少及骨矿物质代谢紊乱。
Alcohol Alcohol. 1992 Nov;27(6):619-25.
9
Growth hormone/insulin-like growth factor-1 axis, calciotropic hormones and bone mineral density in young patients with chronic viral hepatitis.慢性病毒性肝炎年轻患者的生长激素/胰岛素样生长因子-1轴、促钙激素与骨密度
Endokrynol Pol. 2015;66(1):22-9. doi: 10.5603/EP.2015.0005.
10
Bone metabolic abnormalities associated with well-controlled type 1 diabetes (IDDM) in young adult women: a disease complication often ignored or neglected.与年轻成年女性中控制良好的 1 型糖尿病(IDDM)相关的骨骼代谢异常:一种常被忽视或忽略的疾病并发症。
J Am Coll Nutr. 2010 Aug;29(4):419-29. doi: 10.1080/07315724.2010.10719859.

引用本文的文献

1
Liver function linked to bone health: A bibliometric of the liver-bone axis.肝功能与骨骼健康的关联:肝-骨轴的文献计量学分析
World J Hepatol. 2025 Feb 27;17(2):103016. doi: 10.4254/wjh.v17.i2.103016.
2
Environmental Cadmium Exposure Exacerbated Bone Loss in NAFLD Mice.环境镉暴露加剧非酒精性脂肪性肝病小鼠的骨丢失。
Biol Trace Elem Res. 2024 Oct;202(10):4586-4595. doi: 10.1007/s12011-023-04016-0. Epub 2023 Dec 15.
3
Vitamin D status & bone health in patients with liver cirrhosis.维生素 D 状态与肝硬化患者的骨骼健康。
Indian J Med Res. 2023 Sep;158(3):284-291. doi: 10.4103/ijmr.IJMR_1144_20.
4
Bone loss in chronic liver diseases: Could healthy liver be a requirement for good bone health?慢性肝病中的骨质流失:健康的肝脏是否是良好骨骼健康的必要条件?
World J Gastroenterol. 2023 Feb 7;29(5):825-833. doi: 10.3748/wjg.v29.i5.825.
5
A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis.原发性硬化性胆管炎患者代谢性骨病的系统评价与荟萃分析
J Clin Med. 2022 Jun 30;11(13):3807. doi: 10.3390/jcm11133807.
6
Common musculoskeletal disorders in chronic liver disease patients.慢性肝病患者的常见肌肉骨骼疾病。
Jt Dis Relat Surg. 2021;32(3):818-823. doi: 10.52312/jdrs.2021.25. Epub 2021 Nov 19.
7
Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease.慢性肝病中肌肉减少症和骨质疏松性肌肉减少症的影响因素及分子发病机制
Life (Basel). 2021 Aug 30;11(9):899. doi: 10.3390/life11090899.
8
Association between osteoporosis and hepatitis B cirrhosis: a case-control study.骨质疏松症与乙型肝炎肝硬化的相关性:病例对照研究。
Afr Health Sci. 2020 Dec;20(4):1610-1616. doi: 10.4314/ahs.v20i4.13.
9
Determining Bone Turnover Status in Patients With Chronic Liver Disease.确定慢性肝病患者的骨转换状态
Cureus. 2021 Apr 13;13(4):e14479. doi: 10.7759/cureus.14479.
10
Macrophage-Stimulating Protein Enhances Osteoblastic Differentiation via the Recepteur d'Origine Nantais Receptor and Extracellular Signal-Regulated Kinase Signaling Pathway.巨噬细胞刺激蛋白通过南特起源受体和细胞外信号调节激酶信号通路增强成骨细胞分化。
J Bone Metab. 2020 Nov;27(4):267-279. doi: 10.11005/jbm.2020.27.4.267. Epub 2020 Nov 30.

本文引用的文献

1
Evaluation and management of osteoporosis in liver disease.肝病中骨质疏松症的评估与管理
Clin Liver Dis. 2005 Nov;9(4):747-66, viii. doi: 10.1016/j.cld.2005.07.003.
2
AGA technical review on osteoporosis in hepatic disorders.美国胃肠病学会关于肝脏疾病中骨质疏松症的技术审查。
Gastroenterology. 2003 Sep;125(3):941-66. doi: 10.1016/s0016-5085(03)01062-x.
3
Osteoporosis in liver diseases and after liver transplantation.
J Hepatol. 2003 Jun;38(6):856-65. doi: 10.1016/s0168-8278(03)00143-0.
4
Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption.高于平均水平的夏季阳光照射对血清25-羟基维生素D和钙吸收的影响。
J Clin Endocrinol Metab. 2002 Nov;87(11):4952-6. doi: 10.1210/jc.2002-020636.
5
Clinical review 144: Estrogen and the male skeleton.临床综述144:雌激素与男性骨骼
J Clin Endocrinol Metab. 2002 Apr;87(4):1443-50. doi: 10.1210/jcem.87.4.8417.
6
Guidelines on the management of osteoporosis associated with chronic liver disease.慢性肝病相关性骨质疏松症管理指南
Gut. 2002 Feb;50 Suppl 1(Suppl 1):i1-9. doi: 10.1136/gut.50.suppl_1.i1.
7
Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis.
Dig Dis Sci. 2000 Jul;45(7):1392-9. doi: 10.1023/a:1005568406664.
8
Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.病毒性肝硬化患者的骨密度、血清胰岛素样生长因子I及骨转换标志物
Hepatology. 1998 Sep;28(3):695-9. doi: 10.1002/hep.510280315.
9
Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment.
J Hepatol. 1998 Jan;28(1):122-31. doi: 10.1016/s0168-8278(98)80211-0.
10
Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis.胰岛素样生长因子1在肝硬化患者中的营养及预后意义
Nutrition. 1997 Mar;13(3):185-90. doi: 10.1016/s0899-9007(96)00399-1.

慢性肝病中的骨矿物质密度与矿物质代谢紊乱

Bone mineral density and disorders of mineral metabolism in chronic liver disease.

作者信息

George Joe, Ganesh Hosahithlu K, Acharya Shrikrishna, Bandgar Tushar R, Shivane Vyankatesh, Karvat Anjana, Bhatia Shobna J, Shah Samir, Menon Padmavathy S, Shah Nalini

机构信息

Department of Endocrinology, KEM Hospital, Parel, Mumbai 400012, India.

出版信息

World J Gastroenterol. 2009 Jul 28;15(28):3516-22. doi: 10.3748/wjg.15.3516.

DOI:10.3748/wjg.15.3516
PMID:19630107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2715978/
Abstract

AIM

To estimate the prevalence and identify the risk factors for metabolic bone disease in patients with cirrhosis.

METHODS

The study was performed on 72 Indian patients with cirrhosis (63 male, nine female; aged < 50 years). Etiology of cirrhosis was alcoholism (n = 37), hepatitis B (n = 25) and hepatitis C (n = 10). Twenty-three patients belonged to Child class A, while 39 were in class B and 10 in class C. Secondary causes for metabolic bone disease and osteoporosis were ruled out. Sunlight exposure, physical activity and dietary constituents were calculated. Complete metabolic profiles were derived, and bone mineral density (BMD) was measured using dual energy X ray absorptiometry. Low BMD was defined as a Z score below -2.

RESULTS

Low BMD was found in 68% of patients. Lumbar spine was the most frequently and severely affected site. Risk factors for low BMD included low physical activity, decreased sunlight exposure, and low lean body mass. Calcium intake was adequate, with unfavorable calcium: protein ratio and calcium: phosphorus ratio. Vitamin D deficiency was highly prevalent (92%). There was a high incidence of hypogonadism (41%). Serum estradiol level was elevated significantly in patients with normal BMD. Insulin-like growth factor (IGF) 1 and IGF binding protein 3 levels were below the age-related normal range in both groups. IGF-1 was significantly lower in patients with low BMD. Serum osteocalcin level was low (68%) and urinary deoxypyridinoline to creatinine ratio was high (79%), which demonstrated low bone formation with high resorption.

CONCLUSION

Patients with cirrhosis have low BMD. Contributory factors are reduced physical activity, low lean body mass, vitamin D deficiency and hypogonadism and low IGF-1 level.

摘要

目的

评估肝硬化患者代谢性骨病的患病率并确定其危险因素。

方法

对72例印度肝硬化患者(63例男性,9例女性;年龄<50岁)进行了研究。肝硬化的病因包括酒精中毒(n = 37)、乙型肝炎(n = 25)和丙型肝炎(n = 10)。23例患者属于Child A级,39例属于B级,10例属于C级。排除代谢性骨病和骨质疏松症的继发原因。计算阳光暴露、体力活动和饮食成分。得出完整的代谢谱,并使用双能X线吸收法测量骨密度(BMD)。低骨密度定义为Z值低于-2。

结果

68%的患者存在低骨密度。腰椎是最常且最严重受影响的部位。低骨密度的危险因素包括体力活动少、阳光暴露减少和瘦体重低。钙摄入量充足,但钙与蛋白质的比例以及钙与磷的比例不理想。维生素D缺乏非常普遍(92%)。性腺功能减退的发生率很高(41%)。骨密度正常的患者血清雌二醇水平显著升高。两组患者的胰岛素样生长因子(IGF)1和IGF结合蛋白3水平均低于年龄相关的正常范围。低骨密度患者的IGF-1显著更低。血清骨钙素水平低(68%),尿脱氧吡啶啉与肌酐比值高(79%),这表明骨形成低而骨吸收高。

结论

肝硬化患者存在低骨密度。促成因素包括体力活动减少、瘦体重低、维生素D缺乏、性腺功能减退和IGF-1水平低。